| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 328,684 | 341,523 | 371,708 | 338,792 | | Cost of Revenue | 264,824 | 287,500 | 310,665 | 274,167 | | | Gross Profit | 63,860 | 54,023 | 61,043 | 64,625 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,591 | 36,892 | 35,637 | 36,579 | | Non Recurring | 83 | (83) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,280 | 17,214 | 25,406 | 28,046 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 290 | 1,229 | 8,901 | 2,417 | | Earnings Before Interest And Taxes | 26,570 | 18,443 | 35,590 | 31,864 | | Interest Expense | 6,463 | 6,557 | 4,278 | 4,439 | | Income Before Tax | 20,107 | 11,886 | 31,312 | 27,425 | | Income Tax Expense | 6,914 | 2,728 | 10,819 | 7,401 | | Minority Interest | 119 | 1,046 |
-
|
-
| | | | Net Income From Continuing Ops | 12,147 | 10,204 | 20,493 | 20,024 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,312 | 10,204 | 20,493 | 20,024 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,312 | $10,204 | $20,493 | $20,024 |
|
0.51% Nasdaq 
Income Statement
